HEIGHT IN CHILDREN WHO ARE TREATED WITH DIALYSIS AND UNDERGO KIDNEY TRANSPLANTION

DOI: https://doi.org/10.29296/25877305-2018-02-12
Download full text PDF
Issue: 
2
Year: 
2018

S. Baiko (1), Candidate of Medical Sciences; Professor A. Sukalo (1, 2), MD, Academician of the National Academy of Sciences of Belarus 1-Belorussian State Medical University, Minsk, Belarus 2-National Academy of Sciences of Belarus, Minsk

The paper shows height trends in 118 children who are treated with dialysis and have undergone kidney transplantation. At the start of renal replacement treatment, the height standard deviation scores (SDS) in the patients were -1.16±1.74 with a need for growth hormone therapy in 28%.

Keywords: 
urology
height
children
dialysis
kidney transplantation
growth hormone



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Fine R. Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective // Pediatr. Nephrol. – 2010; 25 (4): 725–32.
  2. Kuizon B., Salusky I. Growth retardation in children with chronic renal failure // J. Bone Miner. Res. – 1999; 14 (10): 1680–90.
  3. Tonshoff B., Schaefer F., Mehls O. Disturbance of growth hormone – insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment // Pediatr. Nephrol. – 1990; 4 (6): 654–62.
  4. Furth S., Hwang W., Yang C. et al. Growth failure, risk of hospitalization and death for children with end-stage renal disease // Pediatr. Nephrol. – 2002; 17 (6): 450–5.
  5. Rosenkranz J., Reichwald-Klugger E., Oh J. et al. Psychosocial rehabilitation and satisfaction with life in adults with childhood-onset of end-stage renal disease // Pediatr. Nephrol. – 2005; 20 (9): 1288–94.
  6. van Huis M., Bonthuis M., Sahpazova E. et al. Considerable variations in growth hormone policy and prescription in paediatric end-stage renal disease across European countries – a report from the ESPN / ERA–EDTA registry // Nephrol. Dial. Transplant. – 2016; 31 (4): 609–19.
  7. Rees L. Growth hormone therapy in children with CKD after more than two decades of practice // Pediatr. Nephrol. – 2016; 31 (9): 1421–35.
  8. 2012 PrimaryRenalDisease (PRD) codes – ERA–EDTARegistry / ERA–EDTA [Elektronnyj resurs]. – 2012. Rezhim dostupa: https://www.era-edta-reg.org/files/annualreports/pdf/PRD_code_list.pdf – Data dostupa: 12.12.2017.
  9. Schwartz G., Munoz A., Schneider M. et al. New equations to estimate GFR in children with CKD // J. Am. Soc. Nephrol. – 2009; 20 (3): 629–37.
  10. Ljalikov S.A., Sukalo A.V., Kuznetsov O.E. Tsentil'nye harakteristiki antropometricheskih i laboratornyh pokazatelej u detej v sovremennyj period: instruktsija po primeneniju / Grodno, 2009; 94 s.
  11. ESRD Among Children, Adolescents, and Young Adults / 2017 USRDS Annual data report [Elektronnyj resurs]. – 2017. Rezhim dostupa: https://www.usrds.org/2017/view/v2_07.aspx – Data dostupa: 06.01.2018.
  12. Molchanova M.S., Petrosjan E.K., Kazymova S.E. i dr. Analiz narushenija rosta i vesa u detej s hronicheskoj bolezn'ju pochek II–V stadij v Rossii po dannym Rossijskogo registra detej s HPN // Klin. nefrologija. – 2011; 22 (8): 26–30.